Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T01:07:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:44:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Users now see a 403 Forbidden error on the study page, replacing the normal study record content and navigation. The page is currently inaccessible, preventing viewing details for this trial.
    Difference
    0.5%
    Check dated 2026-09-27T01:27:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The header and footer remain visible.
    Difference
    17%
    Check dated 2026-09-20T00:26:35.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor backend or content update to the ClinicalTrials.gov record.
    Difference
    0.0%
    Check dated 2026-08-29T20:15:00.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor deployment update to the site. This change does not modify any study data or visible page content.
    Difference
    0.0%
    Check dated 2026-08-08T10:38:34.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.